MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-17-2041

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2017

Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain.

Priceman Saul J, Tilakawardane Dileshni, Jeang Brook, Aguilar Brenda, Murad John P, Park Anthony K, Chang Wen-Chung, Ostberg Julie R, Neman Josh, Jandial Rahul, Portnow Jana, Forman Stephen J, Brown Christine E

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Purpose: Metastasis to the brain from breast cancer remains a significant clinical challenge, and may be targeted with CAR-based immunotherapy. CAR design optimization for solid tumors is crucial due to the absence of truly restricted antigen expression and potential safety concerns with "on-target off-tumor" activity. Here, we have optimized HER2-CAR T cells for the treatment of breast to brain metastases, and determined optimal second-generation CAR design and route of administration for xenograft mouse models of breast metastatic brain tumors, including multifocal and leptomeningeal disease.Experimental

Design

HER2-CAR constructs containing either CD28 or 4-1BB intracellular costimulatory signaling domains were compared for functional activity in vitro by measuring cytokine production, T-cell proliferation, and tumor killing capacity. We also evaluated HER2-CAR T cells delivered by intravenous, local intratumoral, or regional intraventricular routes of administration using in vivo human xenograft models of breast cancer that have metastasized to the brain.

Results

Here, we have shown that HER2-CARs containing the 4-1BB costimulatory domain confer improved tumor targeting with reduced T-cell exhaustion phenotype and enhanced proliferative capacity compared with HER2-CARs containing the CD28 costimulatory domain. Local intracranial delivery of HER2-CARs showed potent in vivo antitumor activity in orthotopic xenograft models. Importantly, we demonstrated robust antitumor efficacy following regional intraventricular delivery of HER2-CAR T cells for the treatment of multifocal brain metastases and leptomeningeal disease.

Conclusions

Our study shows the importance of CAR design in defining an optimized CAR T cell, and highlights intraventricular delivery of HER2-CAR T cells for treating multifocal brain metastases. Clin Cancer Res; 24(1); 95-105. ©2017 AACR.

Для цитирования: Priceman Saul J, Tilakawardane Dileshni, Jeang Brook, Aguilar Brenda, Murad John P, Park Anthony K, Chang Wen-Chung, Ostberg Julie R, Neman Josh, Jandial Rahul, Portnow Jana, Forman Stephen J, Brown Christine E. Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017. DOI: 10.1158/1078-0432.ccr-17-2041.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.